Pacala Mark L

Insider profile

Performance

Overall performance
3.1
Performance over holding periods
3.1
30 days 90 days 120 days
Average return 13% 8.2% 15.1%
Success rate 100% 68% 82%
Transactions
3 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Pacala Mark L's trades of Starling Oncology, Inc.'s stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Proposed sale
Price
4.00
Quantity 50,000
Value US$200,000
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2025-11-20 2025-11-18
S Sale
26,013 +20.0%
335.90
US$4,989,340 		26,013 +20.0% 335.90 US$4,989,340
2025-11-20 2025-11-18
S Sale
76,933 -45.1%
248.11
US$4,051,138 		76,933 -45.1% 248.11 US$4,051,138
2025-11-20 2025-11-18
S Sale
96,460 -30.5%
300.70
US$3,571,437 		96,460 -30.5% 300.70 US$3,571,437
2025-11-18 2025-11-18
PrS Proposed sale
50,000
4.00
US$200,000 		50,000 4.00 US$200,000
2025-03-28 2025-03-26
B Purchase
90,562 +67.4%
1.04
US$94,338 		90,562 +67.4% 1.04 US$94,338